A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases

W. D. Figg*, Y. Liu, P. Arlen, J. Gulley, S. M. Steinberg, D. J. Liewehr, M. C. Cox, S. Zhai, S. Cremers, A. Parr, X. Yang, C. C. Chen, E. Jones, W. L. Dahut, Donald L. Trump

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish
Pages (from-to)379
Number of pages1
JournalUrologic Oncology: Seminars and Original Investigations
Volume23
Issue number5
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases'. Together they form a unique fingerprint.

Cite this